Top

Published in:

01-03-2009

Differential roles for the inositol phosphatase SHIP in the regulation of macrophages and lymphocytes

Authors: Wai-Hang Leung, Tatyana Tarasenko, Silvia Bolland

Published in: Immunologic Research | Issue 1-3/2009

Abstract

The SH2 domain-containing inositol 5′-phosphatase (SHIP) negatively regulates antigen, cytokine, and Fc receptor signaling pathways in immune cells. Our knowledge of the function of SHIP largely derives from in vitro studies that utilized SHIP-deficient cell lines and immune cells isolated from SHIP null mice. To avoid the pleiotropic effects observed in mice with germline deletion of SHIP, we have used the Cre-lox system to generate SHIP conditional knockout mice with deletion in specific immune cell populations. In this review we summarize our observations from mice with deletion of SHIP in lymphocyte and macrophage lineages and contrast them with earlier data gathered by the analysis of SHIP null mice.

Ono M, Bolland S, Tempst P, Ravetch JV. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature. 1996;383:263–6.PubMedCrossRef

Rohrschneider LR, Fuller JF, Wolf I, Liu Y, Lucas DM. Structure, function, and biology of SHIP proteins. Genes Dev. 2000;14:505–20.PubMed

Rauh MJ, Kalesnikoff J, Hughes M, Sly L, Lam V, Krystal G. Role of Src homology 2-containing-inositol 5’-phosphatase (SHIP) in mast cells and macrophages. Biochem Soc Trans. 2003;31:286–91.PubMedCrossRef

Kalesnikoff J, Sly LM, Hughes MR, Buchse T, Rauh MJ, Cao LP, et al. The role of SHIP in cytokine-induced signaling. Rev Physiol Biochem Pharmacol. 2003;149:87–103.PubMedCrossRef

Parihar R, Trotta R, Roda JM, Ferketich AK, Tridandapani S, Caligiuri MA, et al. Src homology 2-containing inositol 5’-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12. Cancer Res. 2005;65:9099–107.PubMedCrossRef

Damen JE, Liu L, Rosten P, Humphries RK, Jefferson AB, Majerus PW, et al. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3, 4, 5-triphosphate 5-phosphatase. Proc Natl Acad Sci USA. 1996;93:1689–93.PubMedCrossRef

Lioubin MN, Algate PA, Tsai S, Carlberg K, Aebersold A, Rohrschneider LR. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev. 1996;10:1084–95.PubMedCrossRef

Bolland S, Pearse RN, Kurosaki T, Ravetch JV. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity. 1998;8:509–16.PubMedCrossRef

Okada H, Bolland S, Hashimoto A, Kurosaki M, Kabuyama Y, Iino M, et al. Role of the inositol phosphatase SHIP in B cell receptor-induced Ca²⁺ oscillatory response. J Immunol. 1998;161:5129–32.PubMed

10.

Liu Q, Oliveira-Dos-Santos AJ, Mariathasan S, Bouchard D, Jones J, Sarao R, et al. The inositol polyphosphate 5-phosphatase ship is a crucial negative regulator of B cell antigen receptor signaling. J Exp Med. 1998;188:1333–42.PubMedCrossRef

11.

Edmunds C, Parry RV, Burgess SJ, Reaves B, Ward SG. CD28 stimulates tyrosine phosphorylation, cellular redistribution and catalytic activity of the inositol lipid 5-phosphatase SHIP. Eur J Immunol. 1999;29:3507–15.PubMedCrossRef

12.

Freeburn RW, Wright KL, Burgess SJ, Astoul E, Cantrell DA, Ward SG. Evidence that SHIP-1 contributes to phosphatidylinositol 3, 4, 5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. J Immunol. 2002;169:5441–50.PubMed

13.

Sly LM, Rauh MJ, Kalesnikoff J, Song CH, Krystal G. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity. 2004;21:227–39.PubMedCrossRef

14.

Huber M, Helgason CD, Damen JE, Scheid MP, Duronio V, Lam V, et al. The role of the SRC homology 2-containing inositol 5’-phosphatase in Fc epsilon R1-induced signaling. Curr Top Microbiol Immunol. 1999;244:29–41.PubMed

15.

Kimura T, Sakamoto H, Appella E, Siraganian RP. The negative signaling molecule SH2 domain-containing inositol-polyphosphate 5-phosphatase (SHIP) binds to the tyrosine-phosphorylated beta subunit of the high affinity IgE receptor. J Biol Chem. 1997;272:13991–6.PubMedCrossRef

16.

Tridandapani S, Pradhan M, LaDine JR, Garber S, Anderson CL, Coggeshall KM. Protein interactions of Src homology 2 (SH2) domain-containing inositol phosphatase (SHIP): association with Shc displaces SHIP from FcgammaRIIb in B cells. J Immunol. 1999;162:1408–14.PubMed

17.

Tridandapani S, Kelley T, Pradhan M, Cooney D, Justement LB, Coggeshall KM. Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fc gamma immunoreceptor tyrosine-based inhibition motif peptide motif. Mol Cell Biol. 1997;17:4305–11.PubMed

18.

Osborne MA, Zenner G, Lubinus M, Zhang X, Songyang Z, Cantley LC, et al. The inositol 5’-phosphatase SHIP binds to immunoreceptor signaling motifs and responds to high affinity IgE receptor aggregation. J Biol Chem. 1996;271:29271–8.PubMedCrossRef

19.

Huber M, Helgason CD, Damen JE, Scheid M, Duronio V, Liu L, et al. The role of SHIP in growth factor induced signalling. Prog Biophys Mol Biol. 1999;71:423–34.PubMedCrossRef

20.

Scharenberg AM, El-Hillal O, Fruman DA, Beitz LO, Li Z, Lin S, et al. Phosphatidylinositol-3, 4, 5-trisphosphate (PtdIns-3, 4, 5–P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 1998;17:1961–72.PubMedCrossRef

21.

Carver DJ, Aman MJ, Ravichandran KS. SHIP inhibits Akt activation in B cells through regulation of Akt membrane localization. Blood. 2000;96:1449–56.PubMed

22.

Galandrini R, Tassi I, Mattia G, Lenti L, Piccoli M, Frati L, et al. SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells. Blood. 2002;100:4581–9.PubMedCrossRef

23.

Krystal G, Damen JE, Helgason CD, Huber M, Hughes MR, Kalesnikoff J, et al. SHIPs ahoy. Int J Biochem Cell Biol. 1999;31:1007–10.PubMedCrossRef

24.

Ono M, Okada H, Bolland S, Yanagi S, Kurosaki T, Ravetch JV. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell. 1997;90:293–301.PubMedCrossRef

25.

Hashimoto A, Hirose K, Okada H, Kurosaki T, Iino M. Inhibitory modulation of B cell receptor-mediated Ca²⁺ mobilization by Src homology 2 domain-containing inositol 5’-phosphatase (SHIP). J Biol Chem. 1999;274:11203–8.PubMedCrossRef

26.

March ME, Lucas DM, Aman MJ, Ravichandran KS. p135 src homology 2 domain-containing inositol 5’-phosphatase (SHIPbeta) isoform can substitute for p145 SHIP in fcgamma RIIB1-mediated inhibitory signaling in B cells. J Biol Chem. 2000;275:29960–7.PubMedCrossRef

27.

Aman MJ, Walk SF, March ME, Su HP, Carver DJ, Ravichandran KS. Essential role for the C-terminal noncatalytic region of SHIP in FcgammaRIIB1-mediated inhibitory signaling. Mol Cell Biol. 2000;20:3576–89.PubMedCrossRef

28.

Tomlinson MG, Heath VL, Turck CW, Watson SP, Weiss A. SHIP family inositol phosphatases interact with and negatively regulate the Tec tyrosine kinase. J Biol Chem. 2004;279:55089–96.PubMedCrossRef

29.

Dong S, Corre B, Foulon E, Dufour E, Veillette A, Acuto O, et al. T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2. J Exp Med. 2006;203:2509–18.PubMedCrossRef

30.

Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel SM, et al. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 1998;12:1610–20.PubMedCrossRef

31.

Nakamura K, Malykhin A, Coggeshall KM. The Src homology 2 domain-containing inositol 5-phosphatase negatively regulates Fcgamma receptor-mediated phagocytosis through immunoreceptor tyrosine-based activation motif-bearing phagocytic receptors. Blood. 2002;100:3374–82.PubMedCrossRef

32.

Huber M, Helgason CD, Damen JE, Liu L, Humphries RK, Krystal G. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc Natl Acad Sci USA. 1998;95:11330–5.PubMedCrossRef

33.

Brauweiler A, Tamir I, Marschner S, Helgason CD, Cambier JC. Partially distinct molecular mechanisms mediate inhibitory FcgammaRIIB signaling in resting and activated B cells. J Immunol. 2001;167:204–11.PubMed

34.

Neill L, Tien AH, Rey-Ladino J, Helgason CD. SHIP-deficient mice provide insights into the regulation of dendritic cell development and function. Exp Hematol. 2007;35:627–39.PubMedCrossRef

35.

Wahle JA, Paraiso KH, Kendig RD, Lawrence HR, Chen L, Wu J, et al. Inappropriate recruitment and activity by the Src homology region 2 domain-containing phosphatase 1 (SHP1) is responsible for receptor dominance in the SHIP-deficient NK cell. J Immunol. 2007;179:8009–15.PubMed

36.

Loy AL, Goodnow CC. Novel approaches for identifying genes regulating lymphocyte development and function. Curr Opin Immunol. 2002;14:260–5.PubMedCrossRef

37.

Karlsson MC, Guinamard R, Bolland S, Sankala M, Steinman RM, Ravetch JV. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J Exp Med. 2003;198:333–40.PubMedCrossRef

38.

Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, Makar KW, et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity. 2001;15:763–74.PubMedCrossRef

39.

Tarasenko T, Kole HK, Chi AW, Mentink-Kane MM, Wynn TA, Bolland S. T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses. Proc Natl Acad Sci USA. 2007;104:11382–7.PubMedCrossRef

40.

Kashiwada M, Cattoretti G, McKeag L, Rouse T, Showalter BM, Al-Alem U, et al. Downstream of tyrosine kinases-1 and Src homology 2-containing inositol 5’-phosphatase are required for regulation of CD4+CD25+ T cell development. J Immunol. 2006;176:3958–65.PubMed

41.

Ramana CV, Gil MP, Schreiber RD, Stark GR. Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol. 2002;23:96–101.PubMedCrossRef

42.

Lighvani AA, Frucht DM, Jankovic D, Yamane H, Aliberti J, Hissong BD, et al. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc Natl Acad Sci USA. 2001;98:15137–42.PubMedCrossRef

43.

Sullivan BM, Juedes A, Szabo SJ, von Herrath M, Glimcher LH. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci USA. 2003;100:15818–23.PubMedCrossRef

44.

Helgason CD, Kalberer CP, Damen JE, Chappel SM, Pineault N, Krystal G, et al. A dual role for Src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity: aberrant development and enhanced function of b lymphocytes in ship −/− mice. J Exp Med. 2000;191:781–94.PubMedCrossRef

45.

Rickert RC, Roes J, Rajewsky K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 1997;25:1317–8.PubMedCrossRef

46.

Nakamura K, Kouro T, Kincade PW, Malykhin A, Maeda K, Coggeshall KM. Src homology 2-containing 5-inositol phosphatase (SHIP) suppresses an early stage of lymphoid cell development through elevated interleukin-6 production by myeloid cells in bone marrow. J Exp Med. 2004;199:243–54.PubMedCrossRef

47.

Nitschke L, Carsetti R, Ocker B, Kohler G, Lamers MC. CD22 is a negative regulator of B-cell receptor signalling. Curr Biol. 1997;7:133–43.PubMedCrossRef

48.

Poe JC, Fujimoto M, Jansen PJ, Miller AS, Tedder TF. CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux. J Biol Chem. 2000;275:17420–7.PubMedCrossRef

49.

Oliver AM, Martin F, Gartland GL, Carter RH, Kearney JF. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol. 1997;27:2366–74.PubMedCrossRef

50.

Garcia de Vinuesa C, O’Leary P, Sze DM, Toellner KM, MacLennan IC. T-independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Eur J Immunol. 1999;29:1314–23.PubMedCrossRef

51.

Guinamard R, Okigaki M, Schlessinger J, Ravetch JV. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol. 2000;1:31–6.PubMedCrossRef

52.

Martin F, Oliver AM, Kearney JF. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 2001;14:617–29.PubMedCrossRef

53.

Ghansah T, Paraiso KHT, Highfill S, Desponts C, May S, McIntosh JK, et al. Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses. J Immunol. 2004;173:7324–30.PubMed

Title: Differential roles for the inositol phosphatase SHIP in the regulation of macrophages and lymphocytes
Authors: Wai-Hang Leung
Tatyana Tarasenko
Silvia Bolland
Publication date: 01-03-2009
Publisher: Humana Press Inc
Published in: Immunologic Research / Issue 1-3/2009
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI: https://doi.org/10.1007/s12026-008-8078-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Differential roles for the inositol phosphatase SHIP in the regulation of macrophages and lymphocytes

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1-3/2009

Human genetic approaches to diseases of lymphocyte activation

How human leukocytes track down and destroy pathogens: lessons learned from the model organism Dictyostelium discoideum

Structure and function of murine cytomegalovirus MHC-I-like molecules: how the virus turned the host defense to its advantage

Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii

Amplification mechanisms for the enhancement of antigen-mediated mast cell activation

The technological transformation of patient-driven human immunology research